Bioton

company

Warsaw SE ISIN PLBIOTN00029 LEI 259400I5R1L3OPCGII81
Follow Bioton Weekly email: filings, results

Financials

Reported figures only · latest: fiscal 2022 PLN · IFRS
Revenue, last year PLN 233.2M +43% vs prior year
Net income PLN 1.4M −50.7% vs prior year
EPS, diluted -
Operating cash flow PLN 56.1M +915.6% vs prior year
Revenue by fiscal year
PLN 202M
PLN 221.8M
PLN 163M
PLN 233.2M
FY19 FY20 FY21 FY22

Source: ESEF annual reports · latest filing

The long view

Fiscal years as reported · ESEF annual reports, IFRS
Revenue and net income4 fiscal years
  • Revenue
  • Net income
−PLN 200M−PLN 100MPLN 0PLN 100MPLN 200MPLN 300MFY19FY20FY21FY22
Show the numbers
YearRevenueNet income
FY22PLN 233.2MPLN 1.4M
FY21PLN 163MPLN 2.9M
FY20PLN 221.8MPLN 33.9M
FY19PLN 202M−PLN 126.7M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY19FY20FY21FY22
Show the numbers
YearGross marginOperating marginNet margin
FY2241.1%9.1%0.6%
FY2147.7%8.8%1.8%
FY2047.2%21.9%15.3%
FY1950.6%80.9%−62.7%
Free cash flowOperating cash flow minus capital expenditure
−PLN 20MPLN 0PLN 20MPLN 40MFY19FY20FY21FY22
Show the numbers
YearFree cash flow
FY22PLN 26.5M
FY21−PLN 7.4M
FY20PLN 37.3M
FY19−PLN 6.7M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Bioton
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22
Show the numbers
YearBiotonHealthcare median
FY220.6%−80.4%
FY211.8%−71.9%
FY2015.3%−62.2%
FY19−62.7%−46.3%